Evidence map›Paper›PMID 37523713›Full record

ArticleAmerican journal of respiratory cell and molecular biology2023

Prorelaxant E-type Prostanoid Receptors Functionally Partition to Different Procontractile Receptors in Airway Smooth Muscle.

Ajay P Nayak, Elham Javed, Dominic R Villalba, Yinna Wang, Henry P Morelli, Sushrut D Shah, Nicholas Kim, Rennolds S Ostrom, Reynold A Panettieri, Steven S An and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Ajay P NayakCenter for Translational Medicine, Jane and Leonard Korman Lung Institute, Division of Pulmonary, Allergy & Critical Care Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Elham JavedCenter for Translational Medicine, Jane and Leonard Korman Lung Institute, Division of Pulmonary, Allergy & Critical Care Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Dominic R VillalbaCenter for Translational Medicine, Jane and Leonard Korman Lung Institute, Division of Pulmonary, Allergy & Critical Care Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Yinna WangDepartment of Molecular and Cellular Physiology, Albany Medical College, Albany, New York.
Henry P MorelliCenter for Translational Medicine, Jane and Leonard Korman Lung Institute, Division of Pulmonary, Allergy & Critical Care Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Sushrut D ShahCenter for Translational Medicine, Jane and Leonard Korman Lung Institute, Division of Pulmonary, Allergy & Critical Care Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Nicholas KimRutgers Institute for Translational Medicine and Science, Rutgers University, New Brunswick, New Jersey.
Rennolds S OstromDepartment of Biomedical and Pharmaceutical Sciences, School of Pharmacy, Chapman University, Irvine, California; and.
Reynold A PanettieriRutgers Institute for Translational Medicine and Science, Rutgers University, New Brunswick, New Jersey.
Steven S AnRutgers Institute for Translational Medicine and Science, Rutgers University, New Brunswick, New Jersey.ORCID 0000-0003-4723-1888
Dale D TangDepartment of Molecular and Cellular Physiology, Albany Medical College, Albany, New York.ORCID 0000-0002-7339-9249
Raymond B PennCenter for Translational Medicine, Jane and Leonard Korman Lung Institute, Division of Pulmonary, Allergy & Critical Care Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.ORCID 0000-0001-8452-5880
Thomas Jefferson University · USRutgers, The State University of New Jersey · USAlbany Medical Center Hospital · USChapman University · US

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI PANOS G. GEORGOPOULOS · 1988 to 2026
$47.4M
G Protein-Coupled Receptor Signaling in Airway Smooth MuR01HL058506 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RAYMOND B. PENN · 2001 to 2026
$9.3M
Reorganization of the Actin Cytoskeleton in Airway Smooth MuscleR01HL110951 · NHLBI · ALBANY MEDICAL COLLEGE · PI TANG, DALE D. · 2012 to 2022
$3.6M
PLK1 Regulation of Airway Smooth MuscleR01HL130304 · NHLBI · ALBANY MEDICAL COLLEGE · PI TANG, DALE D. · 2016 to 2024
$3.5M
Compartmentalized signaling and crosstalk in airway myocytesR01HL169522 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI RENNOLDS S OSTROM, RAYMOND B. PENN · 2023 to 2026
$2.2M
Optimizing EP receptor subtype targeting for asthma therapyR01HL136209 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI BIRRELL, MARK A, BOYCE, JOSHUA A · 2017 to 2020
$2.2M
Mitochondrial translocator protein: a target for bronchodilationR01HL153602 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI NAYAK, AJAY · 2021 to 2025
$2.0M
Cooperative targeting of pharmacomechanical coupling and the actin cytoskeleton to regulate ASM contractionR01HL145392 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI KRISHNAN, RAMASWAMY, PENN, RAYMOND B. · 2019 to 2022
$1.9M
BETA ADRENERGIC RECEPTOR REGULATION IN HUMAN AIRWAY MUSCR29HL058506 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI PENN, RAYMOND B. · 1997 to 2000
$113k
NHLBI NIH HHS R01 HL058506NHLBI NIH HHS R01 HL110951NHLBI NIH HHS R01 HL130304NHLBI NIH HHS R01 HL136209NHLBI NIH HHS R01 HL145392NHLBI NIH HHS R01 HL153602NHLBI NIH HHS R01 HL169522NHLBI NIH HHS R29 HL058506NIEHS NIH HHS P30 ES005022
6 · The paper itself

Abstract

Prostaglandin E2 imparts diverse physiological effects on multiple airway cells through its actions on four distinct E-type prostanoid (EP) receptor subtypes (EP1-EP4). Gs-coupled EP2 and EP4 receptors are expressed on airway smooth muscle (ASM), yet their capacity to regulate the ASM contractile state remains subject to debate. We used EP2 and EP4 subtype-specific agonists (ONO-259 and ONO-329, respectively) in cell- and tissue-based models of human ASM contraction-magnetic twisting cytometry (MTC), and precision-cut lung slices (PCLSs), respectively-to study the EP2 and EP4 regulation of ASM contraction and signaling under conditions of histamine or methacholine (MCh) stimulation. ONO-329 was superior (<0.05) to ONO-259 in relaxing MCh-contracted PCLSs (log half maximal effective concentration [logEC

Indexed as

ActinsReceptors, Prostaglandin E, EP2 SubtypeCyclic AMP-Dependent Protein KinasesDinoprostoneHistamineHumansLungMuscle, SmoothReceptors, Prostaglandin E, EP4 SubtypeActinsCyclic AMP-Dependent Protein KinasesDinoprostoneHistamineReceptors, Prostaglandin E, EP2 SubtypeReceptors, Prostaglandin E, EP4 SubtypeASMasthmacompartmentalizationG protein-coupled receptorprostaglandin

Identifiers

PMID37523713
PMCPMC10633839
OpenAlexW4385409331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.